Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Pin Huang

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
Plos One|October 16, 2015
Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial CarcinomaHsin-Chih Yeh, Hau-Chern Jan, Wen-Jeng Wu, et al.
Urologic Oncology|May 3, 2016
Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?Hsin-Chih Yeh, Tsu-Ming Chien, Wen-Jeng Wu, et al.
International Journal of Molecular Sciences|April 17, 2019
AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent PathwayChia-Cheng Su, Kun-Lin Hsieh, Po-Len Liu, et al.
Cancer Cell International|April 19, 2019
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionChia-Cheng Yu, Lih-Chyang Chen, Chih-Yung Chiou, et al.
International Journal of Cancer|March 30, 2011
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapyBo-Ying Bao, Jiunn-Bey Pao, Chun-Nung Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomyShu-Pin Huang, Chao-Yuan Huang, Jyh-Seng Wang, et al.
World Journal of Urology|December 24, 2011
Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancerJiunn-Bey Pao, Ying-Pi Yang, Chun-Nung Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2009
Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomyShu-Pin Huang, Li-Chia Huang, Wen-Chien Ting, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 20, 2017
Optimal usage of radium-223 in metastatic castration-resistant prostate cancerTai-Lung Cha, Tony Tong-Lin Wu, Nicholas John Vogelzang, et al.
The Journal of Sexual Medicine|February 13, 2009
The prevalence of and risk factors for androgen deficiency in aging Taiwanese menChia-Chu Liu, Wen-Jeng Wu, Yung-Chin Lee, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Plos One|October 16, 2015
Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial CarcinomaHsin-Chih Yeh, Hau-Chern Jan, Wen-Jeng Wu, et al.
Urologic Oncology|May 3, 2016
Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?Hsin-Chih Yeh, Tsu-Ming Chien, Wen-Jeng Wu, et al.
International Journal of Molecular Sciences|April 17, 2019
AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent PathwayChia-Cheng Su, Kun-Lin Hsieh, Po-Len Liu, et al.
Cancer Cell International|April 19, 2019
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionChia-Cheng Yu, Lih-Chyang Chen, Chih-Yung Chiou, et al.
International Journal of Cancer|March 30, 2011
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapyBo-Ying Bao, Jiunn-Bey Pao, Chun-Nung Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomyShu-Pin Huang, Chao-Yuan Huang, Jyh-Seng Wang, et al.
World Journal of Urology|December 24, 2011
Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancerJiunn-Bey Pao, Ying-Pi Yang, Chun-Nung Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2009
Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomyShu-Pin Huang, Li-Chia Huang, Wen-Chien Ting, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 20, 2017
Optimal usage of radium-223 in metastatic castration-resistant prostate cancerTai-Lung Cha, Tony Tong-Lin Wu, Nicholas John Vogelzang, et al.
The Journal of Sexual Medicine|February 13, 2009
The prevalence of and risk factors for androgen deficiency in aging Taiwanese menChia-Chu Liu, Wen-Jeng Wu, Yung-Chin Lee, et al.
Pageof 22